Patents by Inventor Frank Poelwijk

Frank Poelwijk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10100291
    Abstract: Methods of making deletion mutants of Cas9 proteins and making chimeric Cas9 proteins are described. The Cas9 N- and C-terminal domains may play critical roles in crRNAitracrRNA binding and/or PAM selectivity. To analyze activity, a series of domain exchange mutants between NM and STI (Streptococcus thermophilus Cas9) were made, replacing the N and/or C terminus of NM (Neisseria meningitides Cas9) with the homologous region from STI. The chimeric proteins were then tested using the transcriptional reporter assay described herein altering the guideRNA and/or Cas9 specific PAM within the reporter to determine the influence of the domain exchanges on protein specificity. None of the N-terminal domain swaps between NM and STI endowed NM with novel properties. The C-terminal exchange generated a NM-STI hybrid that was capable of interacting with the STI crRNAitracrRNA complex and was further able to suppress a reporter with a STI specific PAM.
    Type: Grant
    Filed: November 19, 2014
    Date of Patent: October 16, 2018
    Assignee: President and Fellows of Harvard College
    Inventors: Alejandro Chavez, Frank Poelwijk, George M. Church
  • Patent number: 9074199
    Abstract: Methods of making mutant Cas9 proteins are described.
    Type: Grant
    Filed: June 30, 2014
    Date of Patent: July 7, 2015
    Assignee: President and Fellows of Harvard College
    Inventors: Alejandro Chavez, Frank Poelwijk, George M. Church